Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004
about
Vaccines for the common coldVaccines for the common coldAdenovirus transmission--worthy of our attentionPandemic influenza planning: shouldn't swine and poultry workers be included?Matrix and backstage: cellular substrates for viral vaccinesUnusual space-time patterning of the Fallon, Nevada leukemia cluster: Evidence of an infectious etiologyInfluenza and respiratory disease surveillance: the US military's global laboratory-based network.Decreased serologic response in vaccinated military recruits during 2011 correspond to genetic drift in concurrent circulating pandemic A/H1N1 viruses.Clinical Features and Courses of Adenovirus Pneumonia in Healthy Young Adults during an Outbreak among Korean Military PersonnelAcute lower respiratory tract infections in soldiers, South Korea, April 2011-March 2012.A Report of Adult Human Adenovirus Infections in a Tertiary Hospital.Outbreak of febrile respiratory illness associated with adenovirus 11a infection in a Singapore military training cAMP.Spread of adenovirus to geographically dispersed military installations, May-October 2007.Adenovirus infections in hospitalized patients in Israel: epidemiology and molecular characterizationRe-emergent human adenovirus genome type 7d caused an acute respiratory disease outbreak in Southern China after a twenty-one year absence.Retrospective analysis of demographic and clinical factors associated with etiology of febrile respiratory illness among US military basic trainees.Oral adenoviral-based vaccines: historical perspective and future opportunity.Association between barracks type and acute respiratory infection in a gender integrated Army basic combat training populationRisk factors for febrile respiratory illness and mono-viral infections in a semi-closed military environment: a case-control study.Respiratory Infections in the U.S. Military: Recent Experience and ControlDeaths associated with human adenovirus-14p1 infections, Europe, 2009-2010Genotype prevalence and risk factors for severe clinical adenovirus infection, United States 2004-2006.Molecular Epidemiology and Clinical Manifestations of Adenovirus Respiratory Infections in Taiwanese Children.Molecular identification of adenoviruses associated with respiratory infection in Egypt from 2003 to 2010.Adenovirus-vectored vaccines.An adenovirus traffic update: from receptor engagement to the nuclear pore.Respiratory infections in the military.Vaccines for the common cold.Elevated transmission of upper respiratory illness among new recruits in military barracks in Thailand.The subcellular location of antigen expressed by adenoviral vectors modifies adaptive immunity but not dependency on cross-presenting dendritic cells.Evaluation of multiplex type-specific real-time PCR assays using the LightCycler and joint biological agent identification and diagnostic system platforms for detection and quantitation of adult human respiratory adenoviruses.Replication-attenuated Human Adenoviral Type 4 vectors elicit capsid dependent enhanced innate immune responses that are partially dependent upon interactions with the complement system.Reduction in Acute Respiratory Infection Among Military Trainees: Secondary Effects of a Hygiene-Based Cluster-Randomized Trial for Skin and Soft-Tissue Infection Prevention.Thin-section computed tomography findings in 104 immunocompetent patients with adenovirus pneumonia.Molecular Epidemiology of Adenovirus Type 21 Respiratory Strains Isolated From US Military Trainees (1996-2014).Enhanced viral etiological diagnosis of respiratory system infection outbreaks by use of a multitarget nucleic acid amplification assay.Simian adenovirus type 35 has a recombinant genome comprising human and simian adenovirus sequences, which predicts its potential emergence as a human respiratory pathogen.Computational analysis of four human adenovirus type 4 genomes reveals molecular evolution through two interspecies recombination events.Influenza vaccine effectiveness among US military basic trainees, 2005-06 season.Dramatic decline of respiratory illness among US military recruits after the renewed use of adenovirus vaccines.
P2860
Q24201977-D78C2102-7738-4CB4-83D6-6390C171E464Q24235521-D7F6C5D0-EB74-4D97-B2BA-A6F4A1ED5583Q24674502-AE08675C-58A9-4366-9A77-127177BA1072Q24682158-423E7F1A-0034-48A1-B73C-0CA60EC0CAD6Q27025941-25F60382-7C37-4DDA-A07A-98C5CB0D9431Q28661457-89E8EE4F-8CE0-4770-8638-103CCFC52261Q30388377-77EAC88E-140E-4035-8F84-51C5096629C7Q30415565-11A780C7-4EBB-4A9A-A9CF-C138F1B3AEE2Q33438658-21B57BCE-AA50-479F-B72A-3A930AC26718Q33577238-FF9AF7C0-0A52-4F54-8F92-E026B11F5FCAQ33642256-B3B1DCA2-6DC2-4085-945E-460FD29F0751Q33769519-1A941C44-0431-402A-B906-2EAD455099EFQ34194128-604D11C5-1E19-4C0C-B125-E96C5836CC0EQ34596617-A97C484A-3DCC-4494-84C1-038B48013E3AQ34648168-B8143873-D8DE-45A6-9894-6C146BEA68D6Q34686092-3E73F6A5-2207-4940-B015-38AF8E598567Q34746476-D59EB914-EB9B-424F-B3D5-DEA4EF8B73C5Q35350509-DFE8EBB5-97F6-489F-83D9-B2A7F7E8B9F2Q35712381-3454019F-EBF1-47B5-B043-4C715C22C3D9Q35763405-442DEF37-97CC-41F9-9336-6E4FD2B0A169Q36053795-2B1DD026-01B7-4716-8DDC-6202342C1C39Q36117853-8C0AA473-CE74-4462-96D0-AC458097F74BQ36891926-1EC8EA96-DBC8-4554-ACD1-BF0EA97CF2F0Q37586333-CC315170-C836-4C27-B00D-0169330BE334Q37689799-C56E1039-21D8-4FA5-BAFE-D0CEF0F61EEEQ37848821-410BAD7B-C0E3-4560-81F4-55682DC78FCEQ38151079-D8472491-742A-4E43-BB8F-4574E7E7DA98Q38682527-E656B228-91FC-4053-B3E2-5D538B1EBD36Q39173327-2810321A-EE03-40F9-9930-538EC1FA91F6Q39549081-BDAA6029-B7C9-4044-BF77-5933F3D693F9Q39901378-594A50A0-6358-4692-BDB7-AA8A87C32971Q40012391-D0B3F101-742E-4613-9FF8-22A031ED5766Q40622346-DF6AA721-6309-44C1-B37D-72185E0DBED5Q40851615-100405E4-5A14-420D-B794-411E11BEF117Q41275413-B8DE55D7-DE3F-4156-AE92-2569CA652A56Q41766772-AEB1C925-77AE-4062-A85B-36FDEC290E43Q41896479-3B9F27AA-440B-4D98-BCF2-E4D8EB9D9CB9Q42093768-03359C4B-D001-4380-8AAB-A92991402F66Q42173319-B654222E-0309-4F0F-8088-0237B000DAB8Q42207666-4CFF19BA-525B-4ADB-AA93-573AE661D11C
P2860
Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004
@ast
Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004
@en
Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004
@nl
type
label
Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004
@ast
Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004
@en
Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004
@nl
prefLabel
Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004
@ast
Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004
@en
Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004
@nl
P2093
P2860
P3181
P1433
P1476
Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004
@en
P2093
Anthony W Hawksworth
Christian J Hansen
Jennifer Strickler
Joel C Gaydos
Kevin L Russell
Margaret A K Ryan
Marina Irvine
P2860
P304
P3181
P356
10.1016/J.VACCINE.2005.12.062
P407
P577
2006-04-05T00:00:00Z